{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:18:37Z","timestamp":1772119117139,"version":"3.50.1"},"reference-count":21,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the NSFC Incubation Project of Guangdong Provincial People\u2019s Hospital","award":["KY0120220049"],"award-info":[{"award-number":["KY0120220049"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515110294"],"award-info":[{"award-number":["2023A1515110294"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["2022YW030009"],"award-info":[{"award-number":["2022YW030009"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,27]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the prognostic significance of tumour deposit (TD) across different N stages in patients with stage III colon cancer and to develop and validate a novel N staging system that incorporates TD count to improve prediction of cancer-specific survival (CSS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study based on population-based data and external validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Secondary and tertiary care settings; data from the SEER database, a population-based cancer registry capturing cancer incidence and survival information (USA, 2010\u20132017); and a single-centre validation cohort from South China (2015\u20132019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 8739 stage III colon cancer patients from the SEER database who underwent curative surgery were included; 1335 (15.3%) had TD. Patients with &lt;12 examined lymph nodes and those who received neoadjuvant therapy were excluded. An independent external validation cohort included 326 patients from Guangdong Provincial People\u2019s Hospital. Selection criteria were consistent with the SEER cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>The outcome was cancer-specific survival (CSS). The prognostic impact of tumour deposit (TD) and the comparative performance of the novel N staging system versus the AJCC system were evaluated using the Fine-Gray competing risks model, time-dependent area under the curve (AUC) and Brier score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TD was independently associated with poorer CSS: 1 TD (SHR=1.23, 95%\u2009CI 1.04 to 1.47, p=0.017), 2\u20133 TDs (SHR=1.36, 95%\u2009CI 1.17 to 1.58, p&lt;0.001) and &gt;3 TDs (SHR=2.02, 95%\u2009CI 1.73 to 2.35, p&lt;0.001). The adverse effect of TD was more pronounced in N1 compared with N2 patients. Based on these findings and the work of Mayo\n                      <jats:italic>et al<\/jats:italic>\n                      , TDs were converted to metastatic lymph nodes (mLNs) using the following weighting: 1 TD=3 mLNs (N1c), 1 TD=2 mLNs (N1) and 1 TD=1\u2009mLN (N2). The novel N staging system stratified patients as nN1a (1 nLN), nN1b (2\u20133 nLNs), nN2a (4\u20136 nLNs) and nN2b (\u22657 nLNs). This approach showed improved prognostic accuracy compared with AJCC N staging: 3-year AUC (0.623 vs 0.614) and Brier score (0.151 vs 0.157, p&lt;0.001). A similar performance was observed in the external validation cohort: 3-year AUC=0.709\u2009and 5-year AUC=0.684.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TD significantly worsens prognosis in stage III colon cancer, particularly in lower N stages. Incorporating TD counts into the N staging system with different weightings based on N stage enhances prognostic accuracy and risk stratification within stage III disease, particularly for the heterogeneous AJC N1c category. This novel staging system provides better prognostic value and more accurate treatment guidance and should be considered for broader clinical use, subject to further (eg, prospective) validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-099489","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:15:14Z","timestamp":1772115314000},"page":"e099489","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic impact of tumour deposits across N stages in stage III colon cancer: development and validation of a novel N staging system using the SEER database and a Chinese single-centre cohort"],"prefix":"10.1136","volume":"16","author":[{"given":"Waiting","family":"Lam","sequence":"first","affiliation":[{"name":"Guangdong Cardiovascular Institute, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Guangdong Provincial People\u2019s Hospital Affiliated to Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zejian","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Guangdong Provincial People\u2019s Hospital Affiliated to Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guole","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3413-4137","authenticated-orcid":false,"given":"Deqing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Guangdong Provincial People\u2019s Hospital Affiliated to Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"2026022606150504000_16.2.e099489.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026022606150504000_16.2.e099489.2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2013.06.048","article-title":"EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum","volume":"50","author":"van de Velde","year":"2014","journal-title":"Eur J Cancer"},{"key":"2026022606150504000_16.2.e099489.3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/bjs.1800239017","article-title":"Lymphatic spread in cancer of the rectum","volume":"23","author":"Gabriel","year":"1935","journal-title":"J British Surg"},{"key":"2026022606150504000_16.2.e099489.4","unstructured":"Sobin L , Gospodarowicz M , Wittekind C . International union against cancer: TNM classifcation of malignant tumours. 7th edn. West Sussex, United Kingdom: Wiley-Blackwell, 2009."},{"key":"2026022606150504000_16.2.e099489.5","unstructured":"Brierley J , Gospodarowicz M , Wittekind C . International union against cancer: TNM classifcation of malignant tumours. 8th edn. West Sussex, United Kingdom: Wiley-Blackwell, 2017."},{"key":"2026022606150504000_16.2.e099489.6","doi-asserted-by":"publisher","DOI":"10.1111\/his.12936"},{"key":"2026022606150504000_16.2.e099489.7","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1200\/JCO.19.01960","article-title":"Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)","volume":"38","author":"Delattre","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026022606150504000_16.2.e099489.8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.586603","article-title":"The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer","volume":"10","author":"Shi","year":"2020","journal-title":"Front Oncol"},{"key":"2026022606150504000_16.2.e099489.9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.annonc.2021.07.009","article-title":"Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB\/SWOG 80702 phase III study (Alliance)\u2606","volume":"32","author":"Cohen","year":"2021","journal-title":"Ann Oncol"},{"key":"2026022606150504000_16.2.e099489.10","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/SLA.0000000000005355","article-title":"Revised Nodal Staging Integrating Tumor Deposit Counts With Positive Lymph Nodes in Patients With Stage III Colon Cancer","volume":"277","author":"Pyo","year":"2023","journal-title":"Ann Surg"},{"key":"2026022606150504000_16.2.e099489.11","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-4728","article-title":"Development and validation of a novel prognostic nomogram including tumor deposits could better predict survival for colorectal cancer: a population-based study","volume":"9","author":"Bai","year":"2021","journal-title":"Ann Transl Med"},{"key":"2026022606150504000_16.2.e099489.12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/modpathol.2013.239","article-title":"Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis","volume":"27","author":"Gopal","year":"2014","journal-title":"Mod Pathol"},{"key":"2026022606150504000_16.2.e099489.13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bjs\/znae309","article-title":"Tumour deposit count is an independent prognostic factor in colorectal cancer-a population-based cohort study","volume":"112","author":"Lundstr\u00f6m","year":"2024","journal-title":"Br J Surg"},{"key":"2026022606150504000_16.2.e099489.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57041-2"},{"key":"2026022606150504000_16.2.e099489.15","first-page":"12","article-title":"How Best to Play the Role of Tumor Deposits in Stage III Colon Cancer?","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"2026022606150504000_16.2.e099489.16","doi-asserted-by":"crossref","unstructured":"Pei J-P , Zhang C-D , Fu X , et al . n.d. A Modified Tumor-Node-Metastasis Classification for Stage III Colorectal Cancers Based on Treating Tumor Deposits as Positive Lymph Nodes. Front Med 7. doi:10.3389\/fmed.2020.571154","DOI":"10.3389\/fmed.2020.571154"},{"key":"2026022606150504000_16.2.e099489.17","unstructured":"National Cancer Institute . SEER*Stat software, version 8.4.0. 2021. Available: https:\/\/seer.cancer.gov\/seerstat\/"},{"key":"2026022606150504000_16.2.e099489.18","unstructured":"Wu D . Prognostic impact of tumor deposits across N stages in stage III colon cancer: development and validation of a novel N staging system using SEER and a Chinese single-center cohort.2025. Available: https:\/\/doi.org\/10.17605\/OSF.IO\/7KDPH"},{"key":"2026022606150504000_16.2.e099489.19","unstructured":"Wu D , Lam W . Prognostic impact of tumor deposits across N stages in stage III colon cancer: development and validation of a novel N staging system using SEER and a Chinese single-center cohort.2025. Available: https:\/\/doi.org\/10.17605\/OSF.IO\/A67T8"},{"key":"2026022606150504000_16.2.e099489.20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jamasurg.2024.6729","article-title":"Validated Integration of Tumor Deposits in N Staging for Prognostication in Colon Cancer","volume":"160","author":"Sassun","year":"2025","journal-title":"JAMA Surg"},{"key":"2026022606150504000_16.2.e099489.21","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800791"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-099489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:15:18Z","timestamp":1772115318000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-099489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,26]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-099489"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-099489","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}